Perrigo sells generic drug business for $1.55 billion

by on

The sale of the business unit to a private equity firm will provide Perrigo with upward of $2 billion in available cash and serves as part of a “transformation plan” as the company has shifted toward more self-care products.

The sale of the business unit to a private equity firm will provide Perrigo with upward of $2 billion in available cash and serves as part of a “transformation plan” as the company has shifted toward more self-care products.

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: